Master protocol trials could reimagine the future of rare disease research
Researchers from Kennedy Krieger Institute, University of Rochester Medicine and five other institutions released a new publication detailing how master protocol trials could change the future of rare disease research. Using master protocol trials to research rare conditions could decrease costs, im
<p>Researchers from Kennedy Krieger Institute, University of Rochester Medicine and five other institutions released a new publication detailing how master protocol trials could change the future of rare disease research. Using master protocol trials to research rare conditions could decrease costs, im</p>